KJT’s Post

Last week, Rocket Doctor's founder and CEO, Dr. William Cherniak, had the privilege of attending the ITUP (Insure the Uninsured Project) Annual Conference, a cornerstone event that shapes the future of equitable health in California. This prestigious conference is where the heart of California's health policy community comes together to envision the next steps towards achieving health equity across the state. For more than 20 years, ITUP has spotlighted influential voices in health policy, including elected officials, experts, advocates, and many more dedicated to making a difference. At the conference, discussions went deep into health equity, delving into how access to the internet, cultural considerations, and provider availability can play pivotal roles in expanding access to care for patients in need across Urban, Rural and Tribal Communities. This is especially crucial in our mission to empower health equity through technology. Imagine a future where everyone, regardless of location or background, can access quality healthcare services with just a click. At Rocket Doctor, we're not just imagining it; we're working to make it a reality.

New breakthroughs in ALS research are giving hope to patients and families. Dr. Stephen Kolb is at the forefront, working tirelessly to slow ALS progression and improve lives. Read more about his compassionate journey & innovative approach: https://go.osu.edu/Cq3X

In an Industry Breakout Session sponsored by Helix, experts will delve into the dynamic landscape of precision health to address key medical group strategic priorities around high quality care, and more. Participants will discover how precision health initiatives can be strategically employed to drive innovation, growth, and design care. Learn more at https://ow.ly/nGuL50R7RGE

Fellow Foresight for 2024 and Beyond. Thank you DR. ABEL GUEVARA III for the insights. https://lnkd.in/dZ-M7ZDY #HealthDataManagement #DigitalEthics #DataPrivacy #HealthcareInnovation

The availability of more real world data creates tremendous opportunities to identify, quantify, and validate clinical and health economic needs more appropriately, if the right questions and methodologies are applied and data limitations are recognized. This was one of several insights shared in our latest policy webinar. Check out the recording if you missed the discussion yesterday. #innovationeducation #healthpolicy #healthtech https://lnkd.in/ei9Z5x4r 

The pan-Canadian Pharmaceutical Alliance (pCPA) may not be known to many Canadians but, nonetheless, so many Canadian patients are impacted by their work in profound ways. Last week, my colleague, Mark Smithyes, MBA joined the pCPA's CEO, Douglas Clark, in a discussion that touched on the challenges of improving access for patients to new and innovative medicines while supporting payors' interests in optimizing value in drug spending. In many ways, Canada has been a leader in examining this question of "value", particularly our early leadership in embracing the Health Technology Assessments (HTA) framework and, later, in pioneering Product Listing Agreements (PLA) that, together, look beyond the question of PRICE and go deeper into an appreciation of VALUE, both to patients and health systems alike. This has not been easy, and challenges remain, but I have to say that there have been some amazing examples of how industry, payors, governments have been able to bring innovation and goodwill to the table in the interests of finding common ground and finding the "win" for patients. No doubt, serious challenges lie ahead, but the willingness of actors like Douglas Clark and others to speak openly and frankly about those challenges at a forum like this is not only a positive sign, but also speaks volumes about the kind of unique ecosystem that Canada -- and Canadians -- have painstakingly created over the years.

EVENT – THE CASE FOR CONTEMPLATIVE CARE CONFERENCE: From practical techniques to philosophical insights, delve into the heart of contemplative practices at this one-day conference on 1st March. Contemplative care is a fast-growing practice that supports people with life-limiting/shortening conditions which focuses on the individual needs beyond traditional healthcare practices. Join the full-day conference to reflect on just how important contemplative care is, as well as some of the challenges that may come with it: https://lnkd.in/e7uqmtmp

The four main Global Evidence Summit organising partners are joined by three host organisations, one co-sponsor, six program partners and an endorsing organisation, all committed to the #GES2024 theme, ‘Using evidence. Improving lives’. Learn more about these collaborative forces.👇 https://ow.ly/AvGv50RiFEB JBI, Cochrane, The Campbell Collaboration, Guidelines International Network, World Health Organization, American Institutes for Research, Institute of Development Studies, Centre for Evidence and Implementation

Happy 2024 to all, and especially clinical research professionals around the world! 🎉🌍 May this year be filled with groundbreaking discoveries, successful trials, and collaborative advancements in healthcare. Here's to making a positive impact on global health together! #ClinicalResearch #HappyNewYear2024"